about
How Efficient Is My (Medicinal) Chemistry?Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.Novel bisbenzimidazoles with antileishmanial effectiveness.Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agents.1,4-diarylpiperazines and analogs as anti-tubercular agents: synthesis and biological evaluation.Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.Some non-conventional biomolecular targets for diamidines. A short survey.Biological evaluation of bisbenzaldehydes against four Mycobacterium species.Alkanediamide-Linked Bisbenzamidines Are Promising Antiparasitic Agents.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.Parallel solution-phase synthesis of conformationally restricted congeners of pentamidine and evaluation of their antiplasmodial activities.Pharmaceuticals Best Paper Award 2015.Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.Pharmaceuticals: Impact Factor or CiteScore™.Progress Confirmed for Pharmaceuticals in 2016.Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.2015: A Transition Year for Pharmaceuticals?Bisbenzamidines as antifungal agents. are both amidine functions required to observe an anti-Pneumocystis carinii activity?1,2-ethane bis-1-amino-4-benzamidine is active against several brain insult and seizure challenges through anti-NMDA mechanisms targeting the 3H-TCP binding site and antioxidant action.Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents.Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia.Ultra high performance liquid chromatography method for the determination of pentamidine and analog in rat biological fluids.Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.Designing a high performance, stable spectroscopic biosensor for the binding of large and small molecules.Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.2017: A Fruitful Year for Pharmaceuticals.Third International Electronic Conference on Medicinal Chemistry (ECMC-3).Evaluation of bisbenzamidines as inhibitors for matriptase-2.Liquid-phase synthesis of polyhydroquinoline using task-specific ionic liquid technology.Batch and continuous flow preparation of Hantzsch 1,4-dihydropyridines under microwave heating and simultaneous real-time monitoring by Raman spectroscopy. An exploratory studyAntitumor and Anti-Pneumocystis Carinii Activities of Novel BisbenzamidinesBreakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes⁻4Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus KinasesEvidences for the formation of bisbenzamidine-heme complexes in cell-free systemsThree optimized and validated (using accuracy profiles) LC methods for the determination of pentamidine and new analogs in rat plasmaDesign and synthesis of N¹,N⁵-bis[4-(5-alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugsBreakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-5COVID-19: A Brief Overview of the Discovery Clinical Trial
P50
Q26747673-188C77AE-9723-49C6-B027-E1A70562539FQ33208279-A0511744-A26A-463A-B280-21D9DF516A02Q33252044-A7CD5DB5-3804-4757-9BAD-EC9C40314CAFQ33325827-9182364C-8F22-4253-BAFD-8C2DB7CE42FFQ34069002-8BAACDF3-6021-4DFA-A2F0-41C4F6C17573Q34149324-BB4E8169-8EC6-4ED5-998F-C1F657D40418Q37011435-4F6C1593-4E2F-4CF8-B5B8-8845245264FFQ38196072-5F55185E-5A38-45E0-AC01-FB5EDC45461EQ39169291-38253B36-7E46-41FC-AEDF-D636E0FE4A4EQ39552904-ACEC0E3A-297B-4CEE-AF7F-5263C13F9DD5Q39609137-EAB090CD-2DCE-4FF6-B4B7-27119003562FQ40561601-DB33BC3D-3007-4AA3-9EF5-2672A1963288Q41416934-97602BE3-E2E5-4E95-AA8C-5F14527140C4Q42333694-A886F862-6202-4571-BD4C-27BAF255453FQ42366869-E8128A23-22C0-4FC3-AB7D-CD328A74F3F7Q42369516-6E4152EF-45D2-4B70-9AB4-623136460E43Q42390426-59D6258C-0D34-49E5-BB0A-70DA9910632BQ42928550-5223CE0A-6FAB-4FB0-9E23-19D0FE18B735Q42958738-BA99C58E-02EF-432E-A448-11CA4EDAE543Q43081964-ECF9D5E0-2142-4B77-AB4D-5E55C55B6189Q44926788-24ADD0AE-36A1-4543-98B7-71C37A39613BQ45052059-5BE19D01-9791-4C89-9EA5-BE5A5D4C86A4Q46164642-57473EAA-1C88-49D2-A367-A4003DCF3048Q46962599-FA054738-45B0-41F8-9A42-A58854C5C76CQ47733964-B24E64AC-5557-4C62-90CE-BA776B8DC757Q48122716-AD646D75-C81F-4A58-B6C0-7B37AACA34AAQ48365314-3DF4F73A-91D3-4670-BC27-6000B0FD27FCQ48501101-A755466B-D12F-4286-8F72-A8FEC07137BDQ51709078-23F89449-62CA-4538-A69B-41381DC624F8Q53588956-F8EE7943-4AF5-4BC6-AC37-9C436472B473Q57163426-FDDE730F-DD5F-4070-880D-EADBA465F446Q59563853-A06D44FB-6F8F-437D-882E-1D8A0EA1E312Q61453558-77923C6A-BF6B-48E9-BCAE-88269AFD4EB6Q62470829-BD54F1A9-0840-4075-B3D5-058C6A2C3971Q64104943-4A71310D-8735-48A7-B032-0E2B63AD197DQ79786613-A3C56B00-4C16-4469-AD34-B0B4B77E5E2DQ82832455-4899AF51-7C8A-4018-A020-AFA392B2E0C5Q85773304-77724DB0-93BA-43AE-A62A-E4E88A23D00BQ91520982-0A976552-88E1-4C42-BF7F-56C3DD614235Q91923396-D921BE4F-61BF-4B9E-B0D1-D729CB8EF661
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jean Jacques Vanden Eynde
@ast
Jean Jacques Vanden Eynde
@en
Jean Jacques Vanden Eynde
@es
Jean Jacques Vanden Eynde
@nl
Jean Jacques Vanden Eynde
@sl
type
label
Jean Jacques Vanden Eynde
@ast
Jean Jacques Vanden Eynde
@en
Jean Jacques Vanden Eynde
@es
Jean Jacques Vanden Eynde
@nl
Jean Jacques Vanden Eynde
@sl
prefLabel
Jean Jacques Vanden Eynde
@ast
Jean Jacques Vanden Eynde
@en
Jean Jacques Vanden Eynde
@es
Jean Jacques Vanden Eynde
@nl
Jean Jacques Vanden Eynde
@sl
P106
P1153
7004171782
P21
P31
P496
0000-0003-4770-4104